Literature DB >> 16010688

Radiofrequency perforation and conventional needle percutaneous transseptal left heart access: pathological features.

Gruschen R Veldtman1, Gregory J Wilson, Alejandro Peirone, Amanda Hartley, Marvin Estrada, Gunnar Norgard, Ramsey K Leung, Naheed Visram, Lee N Benson.   

Abstract

Perforating radiofrequency (PRF) energy has been used to obtain percutaneous transseptal left heart access. Contrary to ablative radiofrequency (RF), myocardial tissue responses to PRF thermal injury are incompletely defined. In this study, a newly developed RF catheter system for transseptal left atrial entry was compared with conventional needle puncture. Of 15 piglets having transfemoral cardiac catheterization, 12 had transseptal procedures. Needle punctures (NP) and PRF were followed by acute (1 hr; 3 NP, 3 PRF) and chronic necropsy (1 month; 3 NP, 3 PRF). The remaining three piglets had intentional RF aortic perforation through the atrial roof with necropsy at 1 month. Gross and histopathological effects were examined. Acutely, the gross RF lesion was similar to needle puncture. Histologically, the RF lesions had minimal mural thrombus, an inner zone of thermal injury characterized by grayish cytoplasmic staining (elastic trichrome), and a bubbly transformation of the cytoplasm in innermost cardiomyocytes, partial persistence of cross-striations, and an acute inflammatory reaction. The outer extent of the lesion (< 1 mm) was defined by a halo of contraction band necrosis similar to needle puncture. Acute NP injury showed comparable depth and extent of myocyte necrosis (principally contraction bands) with adjacent tissue hemorrhage and edema. At 1 month, a well-developed densely collagenous scar was present in both aortic and transseptal PRF lesions. The extent of acute RF injury is similar to that seen in conventional NP, but the characteristics of tissue insult are different. Both show well-developed healing at 1 month.

Entities:  

Mesh:

Year:  2005        PMID: 16010688     DOI: 10.1002/ccd.20328

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  6 in total

1.  Blunt atrial transseptal puncture using excimer laser in swine.

Authors:  Abdalla A Elagha; Ann H Kim; Ozgur Kocaturk; Robert J Lederman
Journal:  Catheter Cardiovasc Interv       Date:  2007-10-01       Impact factor: 2.692

2.  Fossa ovalis radiofrequency perforation in a difficult case of conventional transseptal puncture for atrial fibrillation ablation.

Authors:  Michela Casella; Antonio Dello Russo; Gemma Pelargonio; Annamaria Martino; Stefano De Paulis; Paolo Zecchi; Fulvio Bellocci; Claudio Tondo
Journal:  J Interv Card Electrophysiol       Date:  2008-02-15       Impact factor: 1.900

3.  Prospective comparison between conventional transseptal puncture and transseptal needle puncture with radiofrequency energy.

Authors:  Stéphane Fromentin; Jean-François Sarrazin; Jean Champagne; Isabelle Nault; François Philippon; Franck Molin; Louis Blier; Gilles O'Hara
Journal:  J Interv Card Electrophysiol       Date:  2011-04-19       Impact factor: 1.900

4.  Radiofrequency needle for transseptal puncture is associated with lower incidence of thromboembolism during catheter ablation of atrial fibrillation: propensity score-matched analysis.

Authors:  Michifumi Tokuda; Seigo Yamashita; Seiichiro Matsuo; Mika Kato; Hidenori Sato; Hirotsuna Oseto; Eri Okajima; Hidetsugu Ikewaki; Ryota Isogai; Kenichi Tokutake; Kenichi Yokoyama; Ryohsuke Narui; Shin-Ichi Tanigawa; Keiichi Inada; Michihiro Yoshimura; Teiichi Yamane
Journal:  Heart Vessels       Date:  2018-04-10       Impact factor: 2.037

5.  Comparing the safety and effectiveness of dedicated radiofrequency transseptal wires to electrified metal guidewires.

Authors:  Jeremiah Wasserlauf; Bradley P Knight
Journal:  J Cardiovasc Electrophysiol       Date:  2022-01-11       Impact factor: 2.942

Review 6.  Transseptal access: A review of contemporary tools.

Authors:  Rachel M Kaplan; Jeremiah Wasserlauf; Bradley P Knight
Journal:  J Cardiovasc Electrophysiol       Date:  2022-03-08       Impact factor: 2.942

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.